Not provided
Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| VU-VICC-HN-0624 | |||
| VU-VICC-IRB-060380 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Cancer Institute (NCI) | NIH |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
RATIONALE: Studying the proteins expressed in samples of tumor tissue from patients with cancer may help doctors identify and learn more about biomarkers related to cancer. It may also help doctors plan better treatment for patients with cancer of the oropharynx.
PURPOSE: This laboratory study is looking at protein expression in tumor tissue samples from patients with cancer of the oropharynx.
OBJECTIVES:
OUTLINE: Archived tumor tissue samples are analyzed for expression of standard immunohistological markers (e.g., p16, p53, and Ki-67) as well as expression of genes identified in a previous gene expression study. Protein expression data are tested for clinical and demographic correlates and compared with gene expression data.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| gene expression analysis | Genetic | profiles of HPV(+) and (-) HNSCCs | ||
| microarray analysis | Genetic | microarray analysis |
| |
| protein expression analysis | Genetic | protein expression analysis | ||
| immunohistochemistry staining method | Other | immunohistochemistry staining method | ||
| laboratory biomarker analysis | Other | laboratory biomarker analysis |
| Measure | Description | Time Frame |
|---|---|---|
| Development of biomarkers for early detection or recurrence surveillance | after 7 months of tissue collection | |
| Identification of therapeutic targets and individualization of treatment based on the biology of squamous cell carcinoma of the oropharynx | after 7months of tissue collection |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
PRIOR CONCURRENT THERAPY:
Not provided
Not provided
Not provided
Not provided
community sample
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Barbara Murphy, MD | Vanderbilt-Ingram Cancer Center | Study Chair |
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D006258 | Head and Neck Neoplasms |
| D000077195 | Squamous Cell Carcinoma of Head and Neck |
| ID | Term |
|---|---|
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D002294 | Carcinoma, Squamous Cell |
| D002277 | Carcinoma |
| D009375 | Neoplasms, Glandular and Epithelial |
| D009370 | Neoplasms by Histologic Type |
Not provided
Not provided
| ID | Term |
|---|---|
| D020869 | Gene Expression Profiling |
| D046228 | Microarray Analysis |
| D007150 | Immunohistochemistry |
| ID | Term |
|---|---|
| D005821 | Genetic Techniques |
| D008919 | Investigative Techniques |
| D046208 | Microchip Analytical Procedures |
| D006651 | Histocytochemistry |
| D003584 | Cytological Techniques |
| D019411 | Clinical Laboratory Techniques |
| D019937 | Diagnostic Techniques and Procedures |
| D003933 | Diagnosis |
| D006652 | Histological Techniques |
| D007158 | Immunologic Techniques |
Not provided
Not provided